Compare Stocks → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CHEKOTCMKTS:NRIFFNASDAQ:SNES Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEKCheck-Cap$3.11+13.1%$2.14$1.25▼$4.63$16.09M0.21727,816 shs439,130 shsNRIFFNuvo Pharmaceuticals$0.75$0.30▼$0.87$8.52M1.577,337 shs3,000 shsSNESSenesTech$0.68-2.8%$0.89$0.52▼$29.04$3.59M0.8879,336 shs56,180 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEKCheck-Cap+13.09%+54.73%+39.46%+49.52%+107.33%NRIFFNuvo Pharmaceuticals0.00%0.00%0.00%0.00%0.00%SNESSenesTech-2.22%-9.01%-26.22%-46.26%-96.26%Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHEKCheck-Cap1.845 of 5 stars3.03.00.00.03.00.01.3NRIFFNuvo PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ASNESSenesTech2.7479 of 5 stars3.54.00.00.02.90.01.3Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEKCheck-Cap2.00Hold$7.00125.08% UpsideNRIFFNuvo PharmaceuticalsN/AN/AN/AN/ASNESSenesTech3.00Buy$3.50412.82% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEKCheck-CapN/AN/AN/AN/A$8.57 per shareN/ANRIFFNuvo Pharmaceuticals$52.41M0.00N/A0.82$1.59 per share0.00SNESSenesTech$1.19M2.95N/AN/A$1.24 per share0.55Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEKCheck-Cap-$19.11M-$3.02N/AN/AN/AN/A-47.85%-43.50%3/29/2024 (Estimated)NRIFFNuvo Pharmaceuticals$2.53M$0.0418.69N/AN/A-2.81%8.02%1.11%N/ASNESSenesTech-$7.71MN/A0.00N/AN/A-646.27%-199.86%-156.79%5/9/2024 (Estimated)Latest CHEK, NRIFF, and SNES EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/29/2024N/ACHEKCheck-CapN/A-$0.87-$0.87N/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEKCheck-CapN/AN/AN/AN/AN/ANRIFFNuvo PharmaceuticalsN/AN/AN/AN/AN/ASNESSenesTechN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEKCheck-CapN/A17.6017.60NRIFFNuvo Pharmaceuticals5.272.672.11SNESSenesTech0.028.497.48OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEKCheck-Cap1.07%NRIFFNuvo PharmaceuticalsN/ASNESSenesTech5.19%Insider OwnershipCompanyInsider OwnershipCHEKCheck-Cap0.48%NRIFFNuvo PharmaceuticalsN/ASNESSenesTech5.32%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCHEKCheck-Cap855.85 million5.82 millionNot OptionableNRIFFNuvo Pharmaceuticals9911.40 millionN/ANot OptionableSNESSenesTech255.14 million4.87 millionNot OptionableCHEK, NRIFF, and SNES HeadlinesSourceHeadlineSenesTech (NASDAQ: SNES) Inks Deal with Wilco Distributing for Pest-Management Productstheglobeandmail.com - March 28 at 12:30 AMSenesTech Signs Wilco Distributing for Evolve™ and ContraPest® Distribution in Agriculture and Professional Rodent Pest Management Marketfinance.yahoo.com - March 27 at 2:46 AMSenesTech (NASDAQ: SNES) Closes Multiple Global Distribution Dealstheglobeandmail.com - March 20 at 5:15 PMSenesTech (NASDAQ: SNES) Expanding Global Reach with Innovative Productstheglobeandmail.com - March 19 at 4:48 AMSenesTech (NASDAQ: SNES) Announces Participation at Emerging Growth Conferencetheglobeandmail.com - March 7 at 2:29 AMSenesTech (NASDAQ: SNES) Posts Fiscal Year 2023 Results, Reports Revenue Growththeglobeandmail.com - March 6 at 4:27 PMSenesTech to Present at the Emerging Growth Conference on March 6, 2024prnewswire.com - March 5 at 9:00 AMSenesTech, Inc. (NASDAQ:SNES) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 24 at 12:35 PMEarnings call: SenesTech reports solid growth and optimistic outlookinvesting.com - February 24 at 7:30 AMSenesTech (NASDAQ: SNES) Continues to Increase Rat Birth Control Product Distributiontheglobeandmail.com - February 24 at 2:17 AMSenesTech Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - February 23 at 10:03 AMSenesTech (NASDAQ: SNES) Promotes Non-Lethal Rodent Birth Control Products at Lytham Investor Forumtheglobeandmail.com - February 22 at 11:28 PMAnalysts Offer Insights on Materials Companies: SenesTech (SNES) and Victoria Gold (OtherVITFF)markets.businessinsider.com - February 22 at 6:27 PMSenesTech, Inc.: SenesTech Announces 2023 Financial Resultsfinanznachrichten.de - February 22 at 1:27 PMSenesTech reports FY resultsmsn.com - February 22 at 1:27 PMSenesTech Announces 2023 Financial Resultsfinance.yahoo.com - February 21 at 8:33 PMSenesTech Announces 2023 Financial Resultsprnewswire.com - February 21 at 4:05 PMEarnings Preview For SenesTechbenzinga.com - February 20 at 6:58 PMSenesTech (SNES) Expands in the Netherlands With Q-chem Dealzacks.com - February 20 at 11:21 AMSenesTech, Inc.: SenesTech Announces Exclusive Distribution Agreement for Evolve Soft Bait in The Netherlandsfinanznachrichten.de - February 16 at 9:12 PMSenesTech to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Wednesday, February 21, 2024finance.yahoo.com - February 15 at 7:00 PMSenesTech to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Wednesday, February 21, 2024prnewswire.com - February 15 at 4:15 PMSenesTech Announces Exclusive Distribution Agreement for Evolve(TM) Soft Bait in The Netherlandsstockhouse.com - February 15 at 2:00 PMSenesTech Announces Exclusive Distribution Agreement for Evolve™ Soft Bait in The Netherlandsfinance.yahoo.com - February 15 at 2:00 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsCheck-CapNASDAQ:CHEKCheck-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.Nuvo PharmaceuticalsOTCMKTS:NRIFFNuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. Nuvo Pharmaceuticals was founded on August 22, 1983 and is headquartered in Mississauga, Canada.SenesTechNASDAQ:SNESSenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. SenesTech, Inc. was incorporated in 2004 and is headquartered in Phoenix, Arizona. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.